Table 1.

Patients baseline characteristics in the SS

Baseline characteristics	N = 11
Gender, n
Male	7
Female	4
Age, median (range), years	56 (32–67)
≤ 60	9
> 60	2
ECOG PS score, n
0	9
1	2
Histology, n
FL	6
DLBCL	5
Ann Arbor stage at enrollment, n
I/II	2
III/IV	9
Number of prior chemotherapy regimens
Median (range)	3(1–8)
Prior rituximab, n	11

SS Safety set, ECOG Eastern Cooperative Oncology Group, PS Performance status, FL Follicular lymphoma, DLBCL Diffuse large B cell lymphoma